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Clinical ostifis fibrosa  cysfica (yon Recldinghausen's disease)  has 
been  found  to  be  associated  with  parathyroid  enlargements.  In 
experimental rickets and other conditions the  enlargement of  these 
glands seems to be secondary to the deficiency.  However, accumu- 
lated clinical evidence favors hyperparathyroidism as the cause of von 
Recklinghausen's  disease.  2  We  have  attempted  to  furnish  experi- 
mental evidence for this view.  The relative tolerance of guinea pigs 
to  parathormone  enabled us  to  induce  in  this  animal  a  condition 
of  severe  but  non-fatal  chronic  hyperparathyroidism,  leading  to 
ostitis  fibrosa  (3, 4). 
We proceeded on the working assumption that while hypercalcemia 
is one indication of parathormone action, its reported absence in guinea 
pigs was not a proof of immunity to parathormone, for parathormone 
might cause the mobilization and excretion of calcium, as well as pro- 
duce its other associated effects, without necessarily raising the serum 
calcium.  Single injections of large doses  (20 units per  100 gm.)  of 
parathormone resulted not only in hypercalcemia but also in hyper- 
phosphatemia,  which were most  pronounced in  young guinea  pigs 
fasted for 60 hours; severe and extensive bone resorption, with injury 
of the bone marrow, occurred only in young guinea pigs.  Prolonged 
treatment  with parathormone  resulted in  varying  degrees  of bone 
1 A preliminary  report of this work has been published  (1).  The bone changes 
were reported in a companion paper (2), to which reference may also be made for 
protocols and for details which have been omitted from the present paper in order 
to avoid unnecessary  duplication. 
Barr and Bulger recently  reviewed the literature of this subject in the Am.*J. 
Med. Sc., 1930, 179, 449. 
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resorption and marrow fibrosis, depending on the dally dose and the 
length of treatment; bone resorption occurred in young animals even 
in the absence of hypercalcemia; hypercalcemia was found after the 
largest  doses,  but  toxic symptoms  (with  hyperphosphatemia) were 
absent even after the  largest  doses when  these  had  been preceded 
by treatment with smaller doses, some compensation having appar- 
ently been established by this means. 
A  procedure similar in principle was employed to produce chronic 
hFperparathyroidism in the dog.  The dog, as is well known, is very 
sensitive to moderate doses of parathormone as well as to overdosage 
(5).  While this sensitiveness has been an advantagein studies of acute 
hyperparathyroidism, it has limited the dog's usefulness in prolonged 
experiments.  Greenwald and Gross  (6)  found negative calcium and 
phosphorus balances (in adult dogs after a prolonged period of para- 
thormone treatment) of such magnitude as to be clearly due to bone 
depletion, though this was not demonstrable by the X-ray (7).  Histo- 
logical  studies  were  not  made.  The  dosage  had  necessarily been 
limited by the need of avoiding fatal effects.  3 
It was our aim not only to induce a condition of chronic hyperpara- 
thyroidism, but also to maintain this condition for periods as long as 
possible, in order to allow the most definite development of the bone 
lesions.  We preferred young animals on an a  priori  assumption that 
bone changes may be expected to be more pronounced in an actively 
growing animal.  This assumption has found its experimental justifica- 
tion in the standard methods for the production of rickets.  The more 
pronounced effects of parathormone upon  the  serum calcium which 
we have observed in actively growing animals may be related to the 
greater availability of their calcium reserves. 
After having established the limits of safe and effective parathor- 
mone dosage at different levels of calcium intake (9), we studied the 
responses of serum calcium and phosphorus to single parathormone 
3 The results of Morgan and Garrison (8), showing  the influence  of vitamin D on 
response to parathormone, were reported after most of the present study had been 
completed.  Among  their dogs there was one 3.5 months old at the beginning of 
the experiment, on an adequate diet, which received repeated parathormone treat- 
ment for 5 weeks.  They did not report on the mineral metabolism of this dog, or 
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injections,  which are  different in  chronic hyperparathyroidism from 
the typical responses of normal dogs, and tested in dogs the assump- 
tion of immunity that has been advanced to  explain the absence of 
hypercaicemia in man after repeated parathormone injections (10, 11). 
The bone changes were studied by histological methods and the find- 
ings are given here very briefly, as an indication of a negative mineral 
balance under the various conditions, in presence as well as in absence 
of  hypercalcemia.  They  have  been  reported  in  detail  in  another 
paper (2).  A  chemical study of the effects of chronic hyperparathy- 
roidism upon bone composition will be published later. 
Experimental Methods 
The puppies,  6 to 9 weeks old, and weighing i  to 2 kg. at the beginning of the 
experiments, were of the same series as those reported in the companion paper (2), 
where brief diet notes were given.  We have found our diet--lean meat  supple- 
mented with about 10 per cent canned tomato and 1 cc. cod liver oil--adequate for 
rapid growth over long periods,  even when no calcium  supplement was given, 
although in the latter case osteoporosis developed in controls not receiving para- 
thormone (12). 
Calcium Supplement,~---In order to ascertain the effects of calcium intake, the 
basal (low calcium) diet was given without calcium supplement, and with small, 
adequate and liberal calcium supplements  (10 per cent calcium lactate solution by 
stomach tube, or bone meal and calcium lactate mixed with a small portion of the 
meat mixture).  Calcium supplement was  sometimes  omitted for 1 day before a 
special interpolated test (see page 594), in order to avoid possible effects of ingested 
calcium.  An interval of almost 48 hours was thus allowed, although the serum 
calcium rise after the ingestion of calcium disappeared in parathormone treated 
animals within a few hours (12). 
Parathormone Injections.--Parathormone  (Lilly)  was injected subcutaneously, 
usually at about 4 p.m., unless contraindicated.  Anorexia,  even in the absence 
of hypercalcemia, was a generally  reliable  indication of overdosage,  and of the 
imminence of more urgent symptoms. 
Blood Analyses.--The  food was removed about 18 hours before the blood was 
drawn for analysis.  Blood was drawn from the jugular vein.  Serum calcium was 
determined by the Clark-Collip modification of the Kramer-Tisdall method.  The 
Benedict-Theis method was employed in the serum phosphorus analyses. 
We adopted intervals of about 18 hours after injections of parathormone as most 
suitable for the determination of overdosage effects on the serum calcium  and 
phosphorus (see Discussion,  page 601).  To study the effects of a single dose in 
detail we employed shorter intervals. 
Recovery Periods and Special Tests.--Parathormone was sometimes discontinued 
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when overdosage was suspected.  Parathormone doses were sometimes increased 
in  special  interpolated tests.  In  the  experiments that  were thus  interpolated 
(E-l, E-2, etc.) care was taken not to interfere with the principal object of produc- 
ing and maintaining a state of chronic hyperparathyroidism. 
Serum Calcium and Phosphorus in Chronic Ityperparathyroidism 
In  preliminary experiments  (9)  to  establish  the limits  of safe--or 
highest non-fatal doses,--and effective--or the lowest doses with which 
bone  resorption  could be  demonstrated--we  found that  daily  para- 
thormone injections of 1 unit per kg. at no time resulted in overdosage 
or hypercalcemia at  the  18  hour interval,  even on  a  liberal  calcium 
diet; slight bone resorption indicated a negative mineral balance.  On 
a  low calcium intake an initial dose of  2  units per kg.  could be em- 
ployed, which  could be  raised  gradually  to  6  units  per kg.  without 
symptoms of overdosage; bone resorption and fibrosis were definite. 
An initial dose of 4  units  per kg.  produced hypercalcemia and  over- 
dosage both on low and liberal calcium intakes, presumably due to an 
abundant store of readily available calcium in the tissues. 
The experience gained in the preliminary tests enabled us to avoid 
fatal overdosage and to maintain a  group of puppies in a  condition of 
chronic hyperparathyroidism on varying calcium intakes. 
Liberal Calcium Intake.--Puppy  7 (initial weight 1.3 kg.)  received an average 
calcium supplement of 0.65 gm. daily and during most of the period of treatment 
(106 days) received 2 units of parathormone per kg. daily.  (The details are given 
in Table I.) 
Daily injection of 1.5 to 4 units per kg. was found at first to produce symptoms 
of overdosage, although hypercalcemia was absent (Periods 1, 2 and 3).  Doses of 
about 5 and 4 units per kg.  (Periods 5 and 7, respectively) resulted in more pro- 
nounced symptoms, with hypercalcemia,  while hypercalcemia had been absent or 
slight and no symptoms of overdosage had appeared in the intervening Period 6, 
on 2.5 units per kg.  The animal was therefore continued on about 2 units per kg. 
Its condition remained good. 
The puppy was sensitive  to parathormone throughout: On the 67th day of the 
experiment (Period E-l), on the 97t  h day (Period E-2c) and the 105th day (Period 
E-3b) single doses caused the serum calcium to rise about 1 mg. per unit per kg. 
It is noteworthy that in experimental Periods E-2c and E-3b the rise of serum 
calcium after a single dose of parathormone was accompanied or followed by a rise 
of serum phosphorus (see Discussion, page 601). 
The typical changes of ostitis fibrosa were found at autopsy. TABLE  14 
Course of Chronic Hyperparathyroidism  on a Liberal Calcium Intake 
~o  Daily treatment 
L 
days  kg.  g~.  gin.  u~its 
I  7  1.5  110 1.3  2 
2  17  1.8  150  .60  4 
3  4  2.0  200  .60  8 
4  2  2.0  250  .60  12 
R-1  4  2.0  110  .60  0 
5  4  2.1  240  .6~  10 
R-2  2  210  . 60  0 
6  21  3.5  360  .60  8 
7  3  3.2  12(1  .20  14 
R-3  1  14~  0 
E-1  1  ~  12 
R-4  2  3.0  0  0 
8  7  3.3  300  .65  6 
9  18  4.0  370  .65  8 
E-2a  1  320  .65  0 
2b  1  0 0  0 
2c  1  0  8 
10  6  4.4  465  .65  8 
E-3a  1  0 0  0 
3b  1  0  8 
Serum analyses 
__.i__ 
4  18  11.9  i 
3  18  11.3 
1  20  Lost 
3  18  11.4 
4  18  15.6 
1  18  12.2 
4  18  12.6 
12  24  13.7 
19  21  11.1 
1  20  114.5 
1 
22  17.1  !  I 
5  21  11.5 
5  18  11.2 
12  18  11.0 
Init.  10.8 
3  12.8  8.5 
6  12.6  8.9 
9  12.0  9.3 
12  11.2  9.3 
24  9.81  8.5 
Init.  12.0?  6.4 
3  13.4  7.2 
24  12.0  6.5 
Remarks 
Vomited repeatedly 
No food taken on 2nd day 
Recovery period 
6.3  Anorexia on last day 
Recovery period 
8.9  Condition good 
9.0 
8.6 
7.8  Appetite failed rapidly 
Recovery period 
5.2  Test of effects of a single dose 
Recovery  period.  Refused 
food  s but active 




8.7  Test of effects of a single dos¢ 
of parathormone 
Test of effects of a single dos< 
of  parathormone 
Serum calcium and phosphorus are stated in mg. per 100 cc. 
For convenience of presentation  periods of treatment  with a  given  dose are 
distinguished  by number in the tables from periods of recovery from overdosage 
(R-l,  R-2,  etc.)  and  from  experimental  periods  (E-l,  E-2,  etc.)  interpolated  to 
elucidate certain special problems. 
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Liberal Calcium Supplement after a Control Period on a Low Calcium Supplement. 
--Another puppy (No. 6, initial weight 1.1 kg.) was placed for 6 weeks on an aver- 
age daily calcium supplement of 0.125  gm. and on daily doses of parathormone in- 
creasing  from  2  to  6  units  per  kg.  As  usual,  hypercalcemia associated with 
symptoms of overdosage was found early in the treatment.  The serum calcium 
was, however, normal (10.6 rag. per 100 co.) during the last week of the period, on 
6 units per kg. daily; the serum phosphorus was 7.5 rag. per 100 cc.; the puppy had 
been eating well and gaining weight. 
The daily calcium supplement was then increased to 1.2 gin., the dose of para- 
thormone remaining the same.  Pronounced hypercalcemia (15.3  rag. of calcium 
per 100  cc.)  followed.  The calcium supplement was  reduced to 0.65  rag. daily 
and the parathormone to 4 units per kg.  Hypercalcemia (19.0 and  18.5  rag. of 
calcium per 100  cc.), was followed later by evidence of compensation (12.6 and 
11.3 rag.).  The animal, however, declined with  loss of appetite and other  symp- 
toms of overdosage.  Bone and soft tissue changes due to terminal acute hyper- 
parathyroidism were found, superimposed upon some bone resorption with marrow 
fibrosis due to chronic hyperparathyroidism. 
Thus,  even after a  long period of treatment, doses well tolerated on a  lower 
calcium intake proved fatal on a liberal  calcium intake. 
Calcium Deficient Dict.--Puppy 8  (initial weight 1.1  kg.) received no calcium 
supplement except during a short period of recovery, when calcium administration 
seemed necessary to prevent the animal's decline and death (R-2), and during a 
final experimental period (E-6).  In this animal some of the characteristic phenom- 
ena of chronic hyperparathyroidism were  observed  most  clearly and  the  data 
(given in Table II) are therefore discussed in greater detail. 
The low calcium diet apparently enabled this animal to tolerate relatively large 
doses of parathormone (up to 6 units per kg. in Period 4) without hypercalcemia or 
symptoms  of  overdosage.  Prolonged  parathormone  administration resulted 
eventually in  a  striking  hypocalcemia, which  was  associated with  hyperphos- 
phatemia, which was particularly pronounced when the animal developed tetany 
or rigor (Periods 6, 7 and R-2).  It is noteworthy that when the puppy went into 
tetany its serum calcium was considerably higher and its serum phosphorus lower 
than in tetania parathyreopriva (about 8 and 12 rag. per 100 ec., respectively, as 
compared with about 6 and 15 rag.) (12).  Calcium lactate by stomach tube gave 
prompt relief from tetany; as a  result of continued calcium treatment, the post- 
absorptive serum calcium rose from about 8 rag. per 100 co. to over 9 rag. at  the 
end of Period R-2 and during Period E-1.  To save the life of the animal, para- 
thormone was discontinued for 44 days (Periods 8 and 9); the animal gained weight 
for about 5 weeks; the serum calcium remained consistently low and the serum 
phosphorus rose.  After parathormone administration had been resumed (Period 
10) the serum calcium remained low when not under the influence of the last dose 
of parathormone.  The serum  phosphorus was  definitely lower during the late 
part of the treatment. AARON  BODANSKY  AND  HENRY  L.  JAF;FE 
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days  hg.  gin.  gin.  un~t~ 
7  1.2  1100  2 
17  1.6  1300  4 
5  1.7  180 0  6 
5  2.0  2200  12 
5  2.1  3000  16 
1  80 0  0 
8  2.4  2400  6  1  18  9.~ 
8  18  8.1 
3  2.4  3000  10  3  8.1 
9  2.6  240  .6C  0  1  7.8 
2  9.9 
3  s.7 I 
4  8.9 
7  9.4 




1  0  10  Init.  8.7 
3  8.7 
9  11.C 
22  9.~ 
32  3.3  3400  3  9.9 
6  8.f 
9  8.4 
14  9.2 
17  8.5 
24  8.5 
1  0  Init.  8.C 
3  9.2 
6  8.4 
9  8.8 
12  7.8  8.2 
.  24 
11  3.1  2200  7  7.~ 
2  3.1  2150 
4  18  13.C 
3  18  11.4 
4  18  10.9 
Remarks 
Condition good 
Vomited on last day 
Recovery period 
9.4 
Sensitive to handling 
9.4  Tetanic seizures, frequent a~ 
10.7  first, with respiratory fail. 
7.1  ure,  spasmodic  defecatio~ 
11.0  and  urination;  marke( 
9.4  weakness.  Gradual  im 
9.1  provement in Period R-2 
Controls on values in Perio( 
E-lb  below,  at  the  saint 
ho~ra 
Test of effects of a single do~ 
of parathormone 
Condition relatively good  al 
7.5  first, but getting weaker to 
8.5  ward the end of the period 
8.1  and more sensitive to  hail. 
9.0  dling 
10.0 
10.0  Test of effects of a single dos~ 
12.4  of  parathormone;  tetanit 
10.0  seizure when handled at th~ 
10.5  3 hour interval 
10.1 
10.1 
Serum calcium and phosphorus are stated in mg. per 100 cc. d 
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lent  Serum analyses 
t~ 
[3  0 
8  2 
.~0  0 
.it.  9 
9  6 
.~2  6 
.~2  5 
.it.  7 
9  6 
.~0  7 
.~0  6 
.~0  8 
Remarks 
Note higher calcium value at 
the 8 hour interval 
Test of effects of a single dose; 
rigid when handled 
Progressively  increasing 
weakness  and  skeletal 
deformities 
Test of effects of a single dose 
of parathormone 
Animal refused to eat 
Test of a single large dose 
Bloody diarrhea 
The puppy remained sensitive to single doses of parathormone even in the late 
stages of chronic hyperparathyroidism,  as shown by its serum calcium about 9 hours 
after the injection.  (Periods E-lb, 62nd day; E-2, 95th day; 11, 121st day; E-3b, 
130th day; E-4a, I57th day of the treatment).  Plateau effects were obtained with 
very large doses (E-5 and 3rd day of Period E-6).  The serum phosphorus also 
rose after single doses of parathormone (E-3b and E-4b). 
Thus,  even  toward  the  end  of  the  experiment  immunity  to  parathormone 
had not been established, although, due to the reduction of the readily available 
calcium reserves, the conditions were obviously not favorable to a demonstration 
of a  marked calcium rise from the usually hypocalcemic level, except with very 
large doses.  The serum calcium rise (per 100 cc.) was at first about 0.5 rag. per 
unit per kg., decreasing later. 
The typical changes of ostitis fibrosa were produced in this animal in the severest 
form.  The effect of chronic hyperparathyroidism was thus enhanced by calcium 
deprivation, but was distinct from that of  calcium deprivation as such--osteo- 
porosis, which is easily distinguishable in the gross examination of the skeleton. 
Calcium Deficient Diet  Preceded by an Adequate Calcium Intake.--In  another 
puppy (No.  10, initial weight  1.1  kg.), a  period of about 60 days on a  calcium AARON  BODANSKY  AND  HENRY  L.  JAFFE  599 
deficient diet was preceded by a  period of about  100  days on an average daily 
calcium supplement of 0.2 gm.  Hypercaicemia and anorexia were marked early 
in the treatment on a dose of parathormone of 1.5 to 4 units per kg., and were still 
observed as late as the 67th day of the treatment; hyperphosphatemia (9 to  10 
mg. per 100 cc.) in absence of hypercalcemia was frequent, and hypotonia appeared. 
The dose was reduced to 2 units per kg., and the animal gained weight, shbwing a 
normal serum calcium but a high serum phosphorus (8 to 9 mg. per 100 cc.). 
After the elimination of the calcium supplement, increasing doses (up to 4 units 
per kg.) were required to produce an equal serum calcium elevation, which was 
consistent although slight, and was associated with a  characteristic serum phos- 
phorus  rise  (see  Discussion,  page  601).  The  serum  phosphorus  rose  from  an 
average initial value of 7.0 mg. per 100 cc. to an average of 8.0 mg. within 3 to 9 
hours after the injection. 
During a terminal 25 day period on 20 units of parathormone daily (4 units per 
kg.) a  consistent decline of serum phosphorus occurred from an average of about 
7 mg. per 100 cc. at the beginning of the period to about 6 mg. at its end.  Hyper- 
calcemia and urgent symptoms of overdosage were absent.  On the other hand, 
hypocalcemia  was  prevented by an  average  supplement of 0.1 gin.  of  calcium 
per day. 
The typical lesions of ostitis fibrosa were produced, but not in as severe form as 
in Puppy 8. 
Variations of Calcium Intake.--Puppy  9,  initial weight  2.3  kg.,  received an 
initial daily calcium supplement of 0.2 gin. for 24 days, 0.65 gin. for 57 days, no 
supplement for 59 days and 0.1 gin. for 25 days.  (The  details are given in Table 
nI.) 
On a  supplement of 0.2 gin., early hypercalcemia appeared as  usual, but soon 
disappeared, to reappear (Period 5) when the supplement was increased to 0.65 
gm., the parathormone dose remaining constant (4 units per kg.).  But even on 
this liberal calcium intake hypercalcemia tended  to  disappear  (Periods 5  to  7 
inclusive).  The puppy gained weight during Period 5, on about 3 units per kg.; 
when parathormone was increased to 4 units per kg. (Period 6) symptoms of over- 
dosage  appeared,  without  hypercaicemia, but  with  a  slight  increase in  serum 
phosphorus (as compared with the figures in Periods 5 and R-4); after a decrease of 
the dose to 2 units per kg. (R-4 and 7) the animal gained weight and was otherwise 
in good condition. 
• 2 and 29 days after the elimination of the calcium supplement, serum calcium 
showed definite effects of a single dose  (Periods E-lb and E-2b), but very slight 
effects were shown 25 days later  (Period E-3b).  A tendency to hypocalcemia had 
already appeared, as in Puppy 8.  Severe hypoealcemia, with associated extreme 
effects, as observed in Dog 8, was prevented by a small calcium supplement.  As 
in Dog 10, the final long period of relative overdosage resulted in a gradual decline 
of serum phosphorus. 
The typical changes of ostitis fibrosa were produced, not in as pronounced form 
as in Dog 8, and substantially identical with those in Dog 10. 600  EXPERIMENTAL  CHRONIC  HYPERPARATHYROIDISM 
TABLE  III  4 
Effect of Changes of Calcium Intake upon the Course of Chronic Hyperparathyroidism 
o  ~ 
days  kg. 
1  6  2.0 
2  4  2.0 
R-1  6  2.1 
3  4  2.3 
R-2  2 
4  2  2.1 
R-3  2  2.1 
5  17  3.0 
6  7  2.8 
R-4  8  3.0 
7  25  3.8 
E-la  1 
lb  2 
8  24  4.0 
E-2a  1 
2b  1 
9  25  5.1 
E-3a  1 
3b  1 
10  3  5.2 
E-4  25  5.4 
Daily treatment  Serum analyses 




8  3  18  16.4  Loss of appetite 
0  5  18  11.3  Recovery period 
6  4  20  12.4  6.90verdosagesuspected 
0  Condition good 
8  1  20  11.4  7.3  Vomited on2ndday 
0  2  68  11.0  Recovery period 
8  8  24  15.0  6.5  Appetite  better;  condition 
9  21  15.5  6.3  good 
15  24  10.5  6.1 
12  1  24  12.1  7.0  Appetite decreased toward the 
5  20  11.1  7.0  end of the period 
6  5  21  11.C  5.8  Dose  reduced;  condition 
better 
8  4  24  10.7  5.6  Condition good 
11  18  10.9  6.1 
0 
8  1  Init.  12.4  5.4  Test of effect of single dose at 
3  13.~  5.9  the end of r~gime of libera 
25  11.~  4.8  calcium intake 
8  12  12  10.C  5.5  Condition  good 
15  8  9.6  5.5  Note decreased parathormone 
24  20  9.6  5.1  effect at early intervals 
0 
16  Init.  9.6  6.4  Test of effect of a single dose 
9  12.2  6.6 
8  15  20  8.5  7.4  Notehypocalcemia 
0 
30  Init.  8.7  7.5  Test  of  single  dose.  Note 
9  9.3  7.9  continuing hypocalcemia 
10 
20  3  20  9.9  6.9  Gradual decrease of appetite; 
20  10.1  6.8  refused food on last day of 
113  18  10.8  6.9  the  period.  Note  gradual 
17  18  10.7  6.2  decline  of  serum  phos- 
24  24  10.7  6.1  phorus 
Serum calcium and phosphorus are stated in mg. per 100 cc. AARON BODANSKY AND HENRY L.  JAI~FE  601 
DISCUSSION 
In chronic hyperparathyroidism the curves seem to be quite different 
from those observed in normal dogs after single injections of para- 
thormone (ll); the effect of a  single moderate dose reaches its maxi- 
mum before the 12th hour, and disappears within 18 hours; after large 
doses hypercalcemia may persist beyond that interval (plateau effect); 
when hypercalcemia is absent, the serum phosphorus will frequently 
be raised at the same late interval after an excessive dose.  We there- 
fore consider an interval of at  least  18  hours after  the injection of 
parathormone as suitable for the detection of overdosage in experi- 
mental chronic hyperparathyroidism.  Earlier intervals may be em- 
ployed for a more detailed study of responses to moderate as well as 
large  doses. 
While  the influence of  the  calcium intake on  the  serum calcium 
response  to  parathormone which we  observed was  perhaps  to  be 
assumed a priori, the relative unkmportance of this influence in young 
animals at the beginning of the parathormone treatment is of particu- 
lar interest, indicating the influence of readily available  reserves  on 
the serum calcium after parathormone injections.  The tolerance to 
parathormone that Morgan and Garrison  (8)  found in animals on a 
vitamin free diet is  analogous in some respects to that  found on a 
calcium poor diet later in the treatment. 
While in normal dogs the serum phosphorus is lowered by a single 
dose of parathormone, the serum phosphorus rose in puppies suffering 
from  chronic  hyperparathyroidism at  early intervals  (9 hours  and 
earlier) after a single moderate injection.  Sometimes the increase of 
serum phosphorus was the earliest response and frequently the only 
response to a  single parathormone injection in these dogs, when the 
serum  calcium rose  slightly, if  at  all.  Thus,  after  long periods of 
parathormone  treatment  absence  of  hypercalcemia  points  not  to 
immunity but  to  a  modification of  the  response  to  parathormone. 
We are continuing the study of this phase of the subject. 
The similarity between the association of low serum calcium and high 
serum  phosphorus in  chronic hyperparathyroidism on  low  calcium 
diets and that observed in renal rickets suggests further investigation. 
The hyperphosphatemia distinguishing experimental chronic hyper- 
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phatemia found in  the  clinical  cases  of ostitis fibrosa  cystica  (von 
Recklinghausen's disease).  This difference may be due to the age of 
the animal, as well as to the method of treatment which frequently 
approached the limit of the dog's tolerance.  There are,  of course, 
many differences between the experimental procedure and the spon- 
taneous clinical process.  Age and species differences, as well as the 
duration of the state of hyperparathyroidism are among the factors 
that may affect the various associated phenomena. 
We have found, for instance, ready bone resorption after single and 
repeated doses of parathormone in young guinea pigs, but not in the 
adult (2, 4).  Hirsch (13) suggested that the clinical condition begins 
frequently  in  childhood and  has  a  long  course  before  it  becomes 
clinically obvious. 
The influence of the species factor is illustrated by a comparison with 
our results in chronic hyperparathyroidism of guinea pigs (4).  As a 
result of previous treatment with smaller doses, a modified response to 
parathormone appeared both in the guinea pig and  in  the  dog, and 
toxic symptoms tended to disappear.  In that stage, hypercalcemia 
was observed in the guinea pig without hyperphosphatemia, while in 
the  dog,  hyperphosphatemia was  present,  while hypercalcemia was 
frequently absent, particularly on a limited calcium intake. 
The common symptoms of chronic hyperparathyroidism were most 
severe in  Puppy  8,  on  a  calcium  deficient diet,  but  were present, 
although in not as severe form, in the other puppies.  Among these 
the most important were general hypotonia, muscular weakness and 
bone deformities with frequent fractures--also characteristic findings 
in clinical cases of hyperparathyroidism. 
The essential bone lesions of ostitis fibrosa, which were generalized 
(involving all the skeletal bones studied--skull, jaw bone, long bones, 
ribs), were most severe on low calcium diets, but were distinct from the 
effects of low calcium diets as such.  While calcium deficiency per se 
is quite compatible with rapid growth, parathormone administration 
retarded bone formation and growth in a  very striking manner (2). 
Extensive bone and marrow fibrosis, with the production of osteoid 
tissue and cysts, was the end result of the drastic combined effects of 
calcium  deficiency  and  chronic  hyperparathyroidism.  In  dietary AARON  BODANSKY  AND HENRY  L. JAFFE  603 
calcium deficiency  a certain economy of calcium is still possible.  With 
chronic hyperparathyroidism added, it was rendered more difficult. 
S~ARY 
i.  On a  low calcium intake hypercalcemia tended to  disappear  in 
chronic hyperparathyroidism on  a  given dose  of parathormone  (as 
large as 6 units per kg.), apparently due to the reduction of a readily 
available calcium reserve.  An increase of either the calcium intake or 
of the daily dose of parathormone caused a rise of serum calcium and 
symptoms of overdosage. 
2.  Hypocalcemia  developed  in  chronic  hyperparathyroidism  in 
young puppies on a low calcium diet.  Tetany occurred at a  calcium 
level which was higher and a phosphorus level which was lower than 
in  tetania  parathyreopriva  of  young  puppies.  About  0.1  gin.  of 
calcium daily was apparently sufficient to maintain the serum calcium 
at a normal level. 
3.  The serum phosphorus in chronic hyperparathyroidism in young 
puppies  continued at or rose above the high level normal for  young 
animals.  Toward the end of long periods of treatment on large para- 
thormone doses (about 5 units per kg.) serum phosphorus approached 
normal levels, pronounced hypercalcemia was  absent but  hypotonia 
and other symptoms of hyperparathyroidism were present. 
4.  A single dose of parathormone caused early in thetreatment and 
on liberal calcium intakes a more marked relative rise of serum calcium 
than in normal adult dogs,  confirming previous observations  (5,  8). 
Later in  the  treatment and  on low  calcium intakes this  effect was 
greatly reduced.  Serum phosphorus  rose after a  single inject.ion of 
parathormone, even when the effect on the serum calcium was slight 
or absent. 
5.  The continued effect of parathormone on serum calcium after pro- 
longed periods of treatment, and the modified response of the  serum 
phosphorus indicate tolerance due to some compensation, rather than 
immunity. 
6.  The  bone  lesions,  presenting  the  essential  features  of  ostitis 
fibrosa cystica (yon Recklinghausen's disease) in varying  degrees of 
severity, depending on the relation of the parathormone dose to the 
calcium intake and to the duration of the treatment, were most promi- 604  EXPERIMENTAL  CHRONIC IFk~PERPARATHYROIDISM 
nent on low calcium intakes, which permitted the use of large doses of 
parathormone without fatal hypercalcemia and without symptoms of 
overdosage. 
7.  Clinical  and  experimental hyperparathyroidism  are  compared 
and discussed. 
The courtesy of  Eli Lilly and Company, who supplied the para- 
thormone used in these experiments, is acknowledged. 
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